Cadonilimab Injection, an independently developed Class 1 innovative biological drug by Kangfang Pharmaceutical Co., Ltd., is the world's first approved PD-1/CTLA-4 bispecific antibody, with its R&D supported by the national Major New Drug Creation Program.
Authentic
Guarantee
Fast Delivery
Privacy Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



